Search

everythinglearnresearchcommunity

for

Search:↓

Men with severe hair loss are more likely to have metabolic syndrome, a condition linked to heart disease.

Men with androgenetic alopecia may have a higher risk of heart rhythm problems.

Hair loss reduces hair thickness and coverage, but drug treatments mainly revive dormant hairs rather than reverse thinning; patients often undervalue their hair loss severity.

PRP may improve hair transplant results, but more research is needed.

Exosome therapy can safely and effectively restore color to gray hair.

Adipose-derived stem cells may help with hair loss, but more research is needed.

Psoriasis, acne, and hair loss are linked to unhealthy cholesterol levels, increasing heart disease risk.

Phyllotex™ extract was found to significantly promote hair growth and protect against hair loss.

Identified genes linked to male-pattern baldness may help develop new treatments.

Trichoscopy is an effective, noninvasive method for early diagnosis of Female Pattern Hair Loss.

Baldness is linked to a higher risk of coronary artery disease, but not to its severity.

People with alopecia have shorter hair follicles and more c-kit, a stem cell factor receptor, which could predict how the condition progresses.

Oral and topical 5-alpha reductase inhibitors affect DHT levels and hair density differently in treating hair loss.

New methods reliably assess hair regrowth and scalp health in hair loss patients.

Combined oral minoxidil and finasteride significantly improve hair density in men with male pattern baldness.

The herbal extract is as effective and safe as 3% minoxidil for treating hair loss.

PRP treatment mildly to moderately improves hair loss in most men with AGA.

Dutasteride injections can help hair growth in androgenic alopecia but need more research for long-term use.

Microneedling with platelet-rich plasma and minoxidil improves hair growth more than just minoxidil in men with hair loss.

Early-onset male hair loss may be linked to higher cardiovascular risk.

Men with early-onset hair loss have more heart disease risk factors.

Autologous cellular micrografts improve hair density and thickness in the short term for androgenetic alopecia.

There's a significant link between the severity of Seborrheic Dermatitis and the pattern of hair loss in people with a family history of hair loss.

Androgenetic alopecia is more common in Saudi men than women.

Cellcurex™ treatment increased hair growth and thickness but caused pain and bleeding.

New models predict male pattern baldness better than old ones but still need improvement.

Botulinum Toxin Type A can increase hair density and improve hair thickness in androgenetic alopecia with minimal side effects.

Young males with severe early-onset hair loss may have a higher risk of metabolic syndrome.

Injectable treatments can effectively and safely improve hair growth in adults with androgenetic alopecia.